All In Biotech

Free tool

FAERS Monitor: Loargys

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761211 or its brand name (Loargys, Pegzilarginase-Nbln). Reports on generic versions are filed under their own applications.

Reports

31

Serious

23

74% of reports

Hospitalization

18

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hyperammonaemia12
  • ammonia increased8
  • decreased appetite5
  • vomiting5
  • pyrexia4
  • somnolence4
  • hyperammonaemic crisis3
  • amino acid level increased2
  • aphthous ulcer2
  • arginine level decreased2
  • asthenia2
  • coma2
  • condition aggravated2
  • drug monitoring procedure incorrectly performed2
  • feeding disorder2

Reports by year received

View as table
YearReports
20251
202630

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,128 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
arginine level decreased21358330.8126401.6509,373
hyperammonaemic crisisSignal319591.36570.539,666
drug monitoring procedure incorrectly performed22055.0536.72,302
amino acid level increased21833.1478.82,054
hyperammonaemiaSignal121632.01047.017,924
ammonia increasedSignal81065.6586.27,467
aphthous ulcer2175.045.8194
feeding disorder266.917.572
coma228.57.529
decreased appetiteSignal514.66.551
somnolenceSignal413.55.435
pyrexiaSignal47.83.118
vomitingSignal57.23.221
condition aggravated24.51.23
asthenia23.60.92

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.